Venetoclax induces profound and sustained responses in patients with relapsed/refractory light-chain amyloidosis.

Hélène Pasquer Karim BelhadjJehan DupuisSylvia OghinaAntoine GalatAmandine LadaiqueAlizée MaarekLouise RoulinRomain GounotElsa PoulotAsma Beldi-FerchiouValérie Molinier-FrenkelCorinne HaiounThibaud DamyFabien Le BrasFrançois Lemonnier

Published in: British journal of haematology (2021)

Keyphrases

multiple myeloma
acute lymphoblastic leukemia
acute myeloid leukemia
hodgkin lymphoma
intellectual disability
diffuse large b cell lymphoma
chronic lymphocytic leukemia
autism spectrum disorder